ACAT2 as a novel therapeutic target to treat fatty liver disease

被引：5
|
作者：
Romeo, Stefano [1 ,2 ,3 ]
机构：
[1] Univ Gothenburg, Sahlgrenska Acad, Wallenberg Lab, Dept Mol & Clin Med,Inst Med, Bruna Straket 16, S-41345 Gothenburg, Vastra Gotaland, Sweden
[2] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden
[3] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Clin Nutr Unit, Catanzaro, Italy
来源：
JOURNAL OF INTERNAL MEDICINE | 2022年 / 292卷 / 02期
关键词：
NASH; Fatty liver; Soat2; MAFLD; NAFLD;
D O I：
10.1111/joim.13460
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：175 / 176
页数：2
相关论文
共 50 条
  • [21] The endoplasmic reticulum as a potential therapeutic target in nonalcoholic fatty liver disease
    Gentile, Christopher L.
    Pagliassotti, Michael J.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2008, 9 (10) : 1084 - 1088
  • [22] Lipophagy: A potential therapeutic target for nonalcoholic and alcoholic fatty liver disease
    Han, Ying-Hao
    He, Xin-Mei
    Jin, Mei-Hua
    Sun, Hu-Nan
    Kwon, Taeho
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 672 : 36 - 44
  • [23] SIRT6: therapeutic target for nonalcoholic fatty liver disease
    Zang, Mengwei
    Gao, Bin
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2022, 33 (12): : 801 - 803
  • [24] Deletion of Gab2 in mice protects against hepatic steatosis and steatohepatitis: a novel therapeutic target for fatty liver disease
    Chen, Shuai
    Kang, Yujia
    Sun, Yan
    Zhong, Yanhong
    Li, Yanli
    Deng, Lijuan
    Tao, Jin
    Li, Yang
    Tian, Yingpu
    Zhao, Yinan
    Cheng, Jianghong
    Liu, Wenjie
    Feng, Gen-Sheng
    Lu, Zhongxian
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2016, 8 (06) : 492 - 504
  • [25] Expression levels of ACAT1 and ACAT2 genes in the liver and intestine of baboons with high and low lipemic responses to dietary lipids
    Kushwaha, RS
    Rosillo, A
    Rodriguez, R
    McGill, HC
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2005, 16 (12): : 714 - 721
  • [26] Is ACAT a novel pharmacological target for the treatment of Alzheimer's disease?
    Puglielli, L
    DRUGS OF THE FUTURE, 2002, 27 (09) : 863 - 868
  • [27] Two human ACAT2 mRNA variants produced by alternative splicing and coding for novel isoenzymes
    Yao, XM
    Wang, CH
    Song, BL
    Yang, XY
    Wang, ZZ
    Qi, W
    Lin, ZX
    Chang, CCY
    Chang, TY
    Li, BL
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2005, 37 (12) : 797 - 806
  • [28] MAIT cells: a novel therapeutic target for alcoholic liver disease?
    Gao, Bin
    Ma, Jing
    Xiang, Xiaogang
    GUT, 2018, 67 (05) : 784 - 786
  • [29] Two Human ACAT2 mRNA Variants Produced by Alternative Splicing and Coding for Novel Isoenzymes
    Xiao-Min YAO~(1
    3 Department of Biochemistry
    Acta Biochimica et Biophysica Sinica, 2005, (12) : 797 - 806
  • [30] New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans
    Eugenia Inzaugarat, Maria
    De Matteo, Elena
    Baz, Placida
    Lucero, Diego
    Claudia Garcia, Cecilia
    Ballerga, Esteban Gonzalez
    Daruich, Jorge
    Sorda, Juan Antonio
    Wald, Miriam Ruth
    Claudia Chernavsky, Alejandra
    PLOS ONE, 2017, 12 (03):
12345